Human tissue kallikreins: A family of new cancer biomarkers

Clinical Chemistry

Volumn 48, Issue 8, 2002, Pages 1198-1205

  Diamandis, Eleftherios P ^a   Yousef, George M ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; KALLIKREIN; KALLIKREIN 10; KALLIKREIN 11; KALLIKREIN 2; KALLIKREIN 6; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

CANCER DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE LOCUS; GENE STRUCTURE; HORMONAL REGULATION; HUMAN; MALE; OVARY CANCER; PROGNOSIS; PROSTATE CANCER; PROTEIN STRUCTURE; REVIEW; TISSUE DISTRIBUTION;

EID: 0036320526     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.8.1198     Document Type: Review

References (84)

1. Characterization of the human kallikrein locus
2. Identification of novel human kallikrein-like genes on chromosome 19q13.3-q13.4
3. The human kallikrein gene family - Implications in carcinogenesis
4. Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4
5. Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4
6. Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region
7. Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer
8. Molecular cloning of a novel human acid phosphatase gene (acpt) that is highly expressed in the testis
9. Identification and molecular characterization of a novel member of the siglec family (SIGLEC9)
10. Genomic organization of the siglec gene locus on chromosome 19q13.4 and cloning of two new siglec pseudogenes
11. Identification and molecular characterization of five novel kallikrein gene 13 (KLK13; KLK-L4) splice variants: Differential expression in human testis and testicular cancer
12. An alternatively spliced variant of KLK4 expressed in prostatic tissue
13. The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family - Genomic characterization, mapping, tissue expression and hormonal regulation
14. Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues
15. Sequence analysis of the human kallikrein gene locus identifies a unique polymorphic minisatellite element
16. Characterization of the mouse and human PRSS17 genes, their relationship to other serine proteases, and the expression of PRSS17 in developing mouse incisors
17. New nomenclature for the human tissue kallikrein gene family
18. The new human tissue kallikrein gene family: Structure, function and association to disease
19. Human kallikreins: Common structural features, sequence analysis and evolution
20. Identification and androgen-regulated expression of two major human glandular kallikrein-1 (hGK-1) mRNA species
21. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element
22. Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease
23. The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation
24. Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression
25. Kallikrein 4 (KLK4), a new member of the human kallikrein gene family is up-regulated by estrogen and progesterone in the human endometrial cancer cell line, KLE
26. Androgen induction of a human prostate-specific kallikrein, hKLK2: Characterization of an androgen response element in the 5′ promoter region of the gene
27. Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies
28. KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer
29. Bioregulation of kinins: Kallikreins, kininogens, and kininases
30. Kallikreins (kininogenases) - A group of serine proteases with bioregulatory actions
31. Structure of mouse kallikrein gene family suggests a role in specific processing of biologically active peptides
32. Human kallikrein hK2 has low kininogenase activity while prostate specific antigen (hK2) has none
33. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid
34. Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation
35. Human glandular kallikrein in breast milk, amniotic fluid, and breast cyst fluid
36. Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumors and in normal breast secretions
37. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids
38. Biochemistry and potential roles of prostatic kallikrein hK2
39. Prostatic kallikrein hK2, but not prostate-specific antigen (hK3), activates single-chain urokinase-type plasminogen activator
40. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein
41. Prostate-specific antigen: A cancer fighter and a valuable messenger?
42. The diagnostic and prognostic utility of prostate specific antigen for diseases of the breast
43. General mechanisms of metastasis
44. Changing views of the role of matrix metalloproteinases in metastasis
45. Structure-function relationship in protein families
46. Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein
47. Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by degenerate PCR
48. Characterization of hK4 (prostase), a prostate-specific serine protease: Activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase
49. Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2
50. Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation
51. Kallikrein and kinin receptor expression in inflammation and cancer
52. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma
53. Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen
54. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): Two closely related, but distinct, kallikreins in the prostate
55. Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer
56. Serum total and free prostate-specific antigen for breast cancer diagnosis in women
57. A novel protease homolog differentially expressed in breast and ovarian cancer
58. Identification of a novel serine protease-like gene, the expression of which is downregulated during breast cancer progression
59. The role for NES1 serine protease as a novel tumor suppressor
60. Cloning of tumor-associated differentially expressed gene-14, a novel serine protease overexpressed by ovarian carcinoma
61. The human KLK8 (neuropsin/ovasin) gene: Identification of two novel splice variants and its prognostic value in ovarian cancer
62. The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells
63. Higher human kallikrein gene 4 (klk4) expression indicates poor prognosis of ovarian cancer patients
64. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer
65. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas
66. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: A new independent and favorable prognostic marker
67. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications
68. Human kallikrein 6 (zyme/protease M/neurosin): A new serum biomarker of ovarian carcinoma
69. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma
70. Human kallikrein 10: A novel tumor marker for ovarian carcinoma?
71. Human kallikrein 11: A new biomarker of prostate and ovarian carcinoma
72. Identification and characterization of klk14, a novel kallikrein serine protease gene located on human chromosome 19q13.4 and expressed in prostate and skeletal muscle
73. Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain
74. Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase
75. Sequence analysis and expression of human neuropsin cDNA and gene
76. The expanded human kallikrein gene family: Locus characterization and molecular cloning of a new member, KLK-L3 (KLK9)
77. Structural characterization and mapping of the normal epithelial cell-specific 1 gene
78. cDNA cloning and expression of a novel serine protease, TLSP
79. Genomic organization, mapping, tissue expression, and hormonal regulation of trypsinlike serine protease (TLSP PRSS20), a new member of the human kallikrein gene family
80. Human kallikrein gene 5 (KLK5) expression by quantitative PCR: An independent indicator of poor prognosis in breast cancer
81. Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues
82. Differential expression of kallikrein gene 5 (KLK5) in cancerous and normal testicular tissues
83. Increased expression of protease M in ovarian tumors
84. Analysis of normal epithelial cell specific-1 (NES1)/kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer